Big Health acquires Limbix, maker of mental health app for depression in adolescents
Big Health, one of the leading companies producing apps to help treat mental health conditions, on Thursday announced it acquired Limbix, developer of a prescription app for adolescent depression.
The terms of the deal were not disclosed, but the acquisition comes at a time when many digital health companies are running into trouble raising money. Developers of prescription digital therapeutics, in particular, have been reeling. Limbix last raised $15 million in late 2021, at the peak of the digital health fundraising boom.
